Scalper1 News
Medical products giant Abbott Laboratories (ABT) missed Q4 sales estimates while meeting profit expectations Wednesday, sending Abbott stock down 2% in morning trading on the stock market today. Earlier it had been down as much as 5.6%. Abbott said revenue totaled $5.66 billion in the quarter, up 0.4% from the year-earlier quarter and about $60 million short of analysts’ consensus. Earnings rose 21% to 58 cents a share, matching estimates. The Scalper1 News
Scalper1 News